Time is ticking: until there is a vaccine against Covid-19, the world is trying to control the further spread of the coronavirus. The US pharmaceutical company Johnson & Johnson is also working flat out on its own vaccine.
It should be there in early 2021, the vaccine that the whole world is eagerly awaiting. According to Johnson & Johnson, the drug should be ready for widespread use by then. The test series will begin with people in September. Overall, Johnson & Johnson plans to produce more than a billion units of the Covid-19 vaccine.
"The world is facing an urgent public health crisis and we are committed to doing our part to make a Covid-19 vaccine available and affordable worldwide as soon as possible," said Alex Gorsky, Chief Executive Officer of Johnson & Johnson.
The pharmaceutical company is cooperating with Biomedical Advanced Research and Development Authority (BARDA) for research on the vaccine. Together, they are investing $ 1 billion to develop a coronavirus vaccine. Clinical phase 1 in humans is scheduled to begin in September 2020 at the latest. After filing with regulatory agencies, the first batches of vaccines may be available for emergencies early next year. This is an extremely accelerated time frame compared to common vaccine developments. Typically, the process of vaccine development spans numerous research stages, which can take anywhere from 5 to 7 years.
Johnson & Johnson vaccine platform:
The US company uses its validated vaccine platform and is also ready to provide resources such as personnel and infrastructure worldwide to successfully bring the vaccine to the healthcare market, the company said. Johnson & Johnson is also expanding production capacity in the United States and other countries. This should ensure the rapid production and worldwide delivery of more than a billion cans.
Johnson & Johnson is one of the world's largest healthcare companies. For this reason, the group also feels obliged to ensure the health of people around the world. Johnson & Johnson's global team of experts is at an unprecedented level. The company began researching potential vaccine candidates back in January 2020.
Covid-19 vaccine candidate was identified:
Based on previous research, the pharmaceutical giant identified a leading Covid-19 vaccine candidate. This now goes into the first production. Johnson & Johnson has been investing billions of dollars in antiviral drugs for more than 20 years. Covid-19 belongs to a group of viruses called coronavirus that attack the respiratory system. There is currently no treatment for the virus.
There is already an automated corona quick test:
The result should be there after just two and a half hours - Bosch Healthcare Solutions and the Northern Irish company Randox Laboratories have presented a quick test for Covid-19, which should be available in Germany from April. Anyone who has symptoms currently has to wait about a day or two in Germany before experiencing the result. Bosch has changed that with the new rapid test. The Covid 19 rapid test is intended for medical facilities and could be used in doctor's offices, hospitals and health centers.
0 comment: